•
Sep 30, 2021

Seres Therapeutics Q3 2021 Earnings Report

Total Revenue
$127M
Previous year: $1.42M
+8843.2%
EPS
$0.72
Previous year: -$0.36
-300.0%
Gross Profit
$126M
Previous year: -$22.4M
-659.6%
Cash and Equivalents
$227M
Previous year: $207M
+9.7%
Free Cash Flow
$124M
Previous year: -$25.9M
-576.8%
Total Assets
$396M
Previous year: $356M
+11.3%

Seres Therapeutics

Seres Therapeutics